The TL 177 imprint identifies a prescription tablet containing Cyclobenzaprine Hydrochloride 10 mg. Cyclobenzaprine is a central-acting skeletal muscle relaxant structurally related to tricyclic antidepressants (TCAs). It is primarily prescribed as an adjunct to rest and physical therapy for the relief of muscle spasms associated with acute, painful musculoskeletal conditions.
Physical Identification
Physical Parameter – Specification
- Active Ingredient – Cyclobenzaprine Hydrochloride (10 mg)
- Form – Solid oral tablet
- Shape – Round
- Color – Yellow
- Imprint – TL 177 debossed on one side
- Drug Class – Central-Acting Skeletal Muscle Relaxant
- CSA Schedule – Non-Controlled (Prescription Only)
- Always verify your pill details with a licensed pharmacist. Pill imprints, colors, and shapes can occasionally differ across manufacturers.
Mechanism of Action
Despite acting on the muscular system, cyclobenzaprine does not act directly on skeletal muscle tissue or neuromuscular junctions. Instead, its therapeutic effects occur primarily in the central nervous system (CNS):
- Brainstem Influx Reduction: Cyclobenzaprine acts predominantly within the brainstem (specifically the locus coeruleus) rather than the spinal cord.
- Inhibition of Motor Neurons: It reduces somatic motor activity by influencing both (gamma) and (alpha) motor systems, decreasing the frequency of motor signals sent down to spastic or strained skeletal muscles.
- Tricyclic Analogy: Because of its structural similarity to tricyclic antidepressants (like amitriptyline), cyclobenzaprine possesses central anticholinergic activity and influences norepinephrine and serotonin activity in the brainstem, contributing to its sedative and muscle-relaxing effects.
- Lack of Spasticity Coverage: It is ineffective for muscle spasms resulting from upper motor neuron or central nervous system diseases, such as cerebral palsy or spinal cord injury.
Indications & Clinical Usage
Cyclobenzaprine 10 mg is indicated as an adjunct to rest and physical therapy for the relief of muscle spasms associated with acute, painful musculoskeletal conditions.
- Duration Limit: Cyclobenzaprine should only be used for short periods (2 to 3 weeks maximum). There is inadequate evidence of effectiveness for more prolonged use, and acute musculoskeletal spasms are generally of short duration.
Dosage Guidance
Dosing should be tailored to the patient’s age, symptom response, and health profile.
- Standard Adult Dosage: The typical dose is 5 mg to 10 mg taken orally three times daily (TID). The maximum recommended daily dosage is 30 mg per day (10 mg 3 times daily).
- Elderly Patients : Elderly individuals clear cyclobenzaprine more slowly, leading to higher drug levels and a greater risk of adverse events (sedation, confusion, dry mouth, urinary retention). Lower doses (starting at 5 mg) are recommended, titrated cautiously.
- Hepatic Impairment: Cyclobenzaprine is extensively metabolized by the liver. In mild liver impairment, dosing should start at 5 mg and be titrated upward with caution. Use is not recommended in moderate to severe hepatic impairment.
Side Effects
Common Side Effects
Due to its anticholinergic and central nervous system activity, the most frequent side effects include:
- Drowsiness / Sedation: The most prominent effect (reported in up to 38% of patients taking 10 mg).
- Dry Mouth: Very common due to anticholinergic block (up to 32%).
- Dizziness & Fatigue: Lightheadedness, sluggishness, or general malaise.
- Gastrointestinal Issues: Nausea, constipation, or indigestion.
Serious & Severe Adverse Effects
Contact emergency medical services or seek immediate care if you experience:
- Serotonin Syndrome: High fever, rapid heart rate, severe agitation, tremors, sweating, muscle rigidity, or hallucinations.
- Cardiovascular Complications: Tachycardia (fast heartbeat), heart palpitations, chest pain, or arrhythmias.
- Severe Anticholinergic Toxicity: Urinary retention, severe confusion, blurred vision, or heat intolerance.
- Allergic Reactions (Anaphylaxis): Swelling of the face, lips, tongue, or throat causing difficulty breathing or swallowing.
Precautions & Contraindications
Major Contraindications
Cyclobenzaprine must not be used under the following conditions:
- Monoamine Oxidase Inhibitor (MAOI) Use: Do not take cyclobenzaprine concurrently with, or within 14 days of discontinuing, an MAO inhibitor (e.g., phenelzine, tranylcypromine, selegiline). Hyperpyretic crisis, severe seizures, and death can occur.
- Recent Heart Attack (Myocardial Infarction): Contraindicated during the acute recovery phase of an MI.
- Arrhythmias & Heart Block: Contraindicated in patients with heart rhythm disorders, conduction abnormalities, or congestive heart failure.
- Hyperthyroidism: Contraindicated due to an increased risk of severe arrhythmias.
Key Warnings & Interactions
- CNS Depression & Driving: Cyclobenzaprine severely impairs mental and physical abilities needed to operate heavy machinery or drive motor vehicles.
- Alcohol & Depressants: Alcohol, benzodiazepines, barbiturates, and opioids compound cyclobenzaprine’s sedative effects, significantly increasing the risk of respiratory or central nervous system depression.
- Serotonergic Drugs: Combining cyclobenzaprine with SSRIs, SNRIs, TCAs, or tramadol raises the risk of life-threatening Serotonin Syndrome.